9 Institutions and Their Take on the Benefits of CBD
As more and more institutions begin to recognize the benefits of CBD, more people agree with utilizing it. See why these institutions want it utilized.
The discovery of the endocannabinoid system resulted from the study of cannabis. The body’s own control system uses certain complex molecules. They fit into chemical receptors like keys and locks.
Cannabidiol (CBD) is a non-psychotropic cannabinoid. It is one of the more than 120 known compounds in cannabis. Cannabinoids are 21-carbon molecules that block or stimulate endocannabinoid receptors.
It’s known that cannabinoids bind to CB1 and/or CB2 receptors. This is the same as endocannabinoids, which are the brain’s own naturally occurring cannabinoids. Many groups and organizations recognize the medical benefits of CBD. Some now openly support legalizing research and use.
Read on to learn more about 10 organizations that support CBD and research.
CBD and the Epilepsy Foundation
The Epilepsy Foundation has several informational resources dedicated to medical cannabis. Their studies of CBD for drug-resistant conditions are often cited. In fact, CBD for seizures is one of the best documented medical uses.
One of the benefits of CBD is its use for the treatment of Dravet Syndrome. Dravet Syndrome is a childhood seizure disorder. It is usually very difficult to treat. Strong conventional seizure medications fail to control it. Clinical and anecdotal evidence shows that cannabis is helpful.
Even better, it doesn’t result in significant side effects. The Epilepsy Foundation has advocated for medical marijuana since 2014.
Benefits of CBD for the World Health Organization
The World Health Organization (WHO), released a report in November 2017. According to the preliminary WHO report, CBD is safe. It notes CBD is not negatively associated with any effects on public health.
CBD does not show potential for abuse. Also, it could have therapeutic value. The report notes therapeutic benefits of CBD for many conditions. The report names illnesses such as Alzheimer’s, psychosis, Crohn’s disease and many others.
Also listed is research into CBD for a diverse range of conditions. This includes searching for neuroprotective, antiepileptic, analgesic, anti-inflammatory, and antitumor properties.
NFL and NFL Players Association
The NFL Players Association asked the NFL to relax policies on cannabis in 2016. In February 2017, the groups agreed to a “less punitive” policy on cannabis use. They also will research CBD for pain management together.
The benefits of CBD have been under study by the NFL Players Association since July 2016. Their interest lies in treatment for pain, concussion, and chronic traumatic encephalopathy. Players tout non-psychoactive CBD as a powerful anti-inflammatory.
Players advocate CBD as an alternative to opioids. Opioids are often prescribed for chronic injury pain. Current and retired players have rapidly jumped on the bandwagon to advocate legalization.
North American Premier Basketball League
The first pro league to accept CBD is the North American Premier Basketball League. In 2017, this 8-team U.S. and Canada minor league reached about 1 million people.
The league named an official CBD supplement partner to their teams. The nutritional supplement is an alternative to prescribed medications. The league supports CBD over opioids, painkiller shots and over the counter medicines.
Muscular Dystrophy Association
MDA supports ongoing research into muscular dystrophy and related diseases. They support the study of the causes and treatments of the disease. This includes CBD.
A patent application to treat Duchenne’s is the result of MDA research. It uses a combination of CBD and other cannabinoids. Cannabinoids contribute to neuromodulation through receptor-based mechanisms. Other MDA-funded studies of medical marijuana treatments confirm certain beneficial effects.
MDA calls for patient rights without interference. They advocate the right for a patient and doctor to determine the best treatment.
American Cancer Society
The American Cancer Society official statement supports cannabis research. They advocate re-classification of marijuana from DEA Schedule I to Schedule II. They also advocate a patient’s right to decide on their own medical care with their doctor.
The American Cancer Society’s website lists alternative and complementary medicines. They do not endorse cannabis but do present current research information. Many patients use cannabis against the side effects of cancer treatments.
They support more research into the risks and benefits of CBD for patients. They also call for compassionate legislation to allow access to cannabis. Their official position is patients and doctors must decide on treatment. They support Federal, State and Local changes to research treatments.
American Nurses Association
The American Nurses Association recognized the benefits of CBD and cannabis in 1984. They renewed their resolution and call for legalization in 2004. They support the right of patients to have safe access to therapeutic cannabis. They also support their members rights to supervise and assist those patients.
National Multiple Sclerosis Society
A significant number of people in the U.S. and U.K are treating their own symptoms with CBD. The official position of the organization is in support of the rights of patients. This includes access to marijuana for medical purposes.
They support legislation to approve such use. They support research into the benefits of marijuana and its derivatives to treat MS. The Society’s members have been vocal advocates of CBD use for spasticity in its forums.
New England Journal of Medicine
The venerable New England Journal of Medicine (NEJM) published a report about CBD in May 2017. A peer-reviewed study of drug-resistant epilepsy in children demonstrated CBD reduced seizures.
It also lent its voice to a position paper to rescind the Federal prohibition of marijuana. NEJM supports cannabis research and uses for seriously ill patients. They advocate the right of physicians to decide to treat with cannabis.
These ten organizations are just a small sample. They represent many more individuals and groups who recognize the benefits of CBD. Worldwide acceptance of the therapeutic uses of the non-psychoactive cannabinoid is growing. We need more scientific research in the U.S.
Systemic change and patient/physician rights are the focus of these ten organizations. For more interesting news and information about CBD, keep reading our blog.